NIR-II Light-Driven Multifunctional Nanozymes PS@CS for Efficient Therapy against Melanoma and Post-tumor Surgery Infection
Nano Letters · 2024
DOI: 10.1021/acs.nanolett.4c05389 ↗Kurz gefasst
Fachartikel in der Zeitschrift Nano Letters, 2024. Verfasst von Rui Gong und 8 weiteren Autor:innen. Beteiligte Einrichtung: Medical Innovation Technology Transformation Center, Shenzhen Key Laboratory of Nanozymes and Translational Cancer Research, Department of Otolaryngo…. Hauptthemen laut MEDLINE: Chitosan, Melanoma, Selenium, Anti-Bacterial Agents. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 26 Literaturangaben. Gefördert von: Basic and Applied Basic Research Foundation of Guangdong Province, Shenzhen Science and Technology Innovation Commission, Development and Reform Commission of Shenzhen Municipality.
Abstract (Originalsprache)
Melanoma, the most prevalent form of skin cancer, is primarily treated with surgical intervention. However, complete tumor cell removal is challenging, and surgical wounds are prone to infection, complicating treatment and increasing costs. The successful treatment of melanoma generally requires multifunctional agents that are coordinated in tumor therapy and wound healing. In this study, we developed platinum (Pt)- and selenium (Se)-based nanozymes, Pt-Se@Chitosan (PS@CS), which exhibit synergistic antitumor and bactericidal efficacy attributed to their multienzyme activity and strong photothermal conversion efficiency. Furthermore, we engineered PS@CS hydrogels capable of inhibiting tumor regrowth postsurgery and accelerating healing of infected wounds. The PS@CS and PS@CS hydrogels presented herein incorporate characteristics including catalytic therapy, photothermal therapy, antibacterial properties, and skin damage healing, providing an innovative and comprehensive therapeutic approach for melanoma treatment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Medical Innovation Technology Transformation Center, Shenzhen Key Laboratory of Nanozymes and Translational Cancer Research, Department of Otolaryngology, Shenzhen Institute of Translational Medicine, The First Affiliat…
- Faculty of Synthetic Biology, Shenzhen University of Advanced Technology, Shenzhen 518107, China.
- Guangzhou Municipal and Guangdong Provincial Key Laboratory of Molecular Target & Clinical Pharmacology, the NMPA and State Key Laboratory of Respiratory Disease, School of Pharmaceutical Sciences, Guangzhou Medical Uni…
- Department of Cardiovascular Surgery, First Center of 301 Chinese PLA General Hospital, Beijing 100853, China.
- Institute of Synthetic Biology, Shenzhen Institute of Advanced Technology, Chinese Academy of Sciences, Shenzhen 518055, China.
- Department of Otolaryngology, Shenzhen Second People's Hospital, The First Affiliated Hospital of Shenzhen University, Shenzhen 518039, China.
ORCID-Profile: Rui Gong
Förderung
- Basic and Applied Basic Research Foundation of Guangdong Province
- Shenzhen Science and Technology Innovation Commission
- Development and Reform Commission of Shenzhen Municipality
- National Natural Science Foundation of China
- Natural Science Foundation of Guangdong Province
- Shenzhen Portion of Shenzhen-Hong Kong Science and Technology Innovation Cooperation Zone
Zitieren
APA
Gong, R., Yang, D., Zhang, C., Abbas, G., Miao, B., Liang, Y., Xu, J., Fang, X., & Ding, H. (2024). NIR-II Light-Driven Multifunctional Nanozymes PS@CS for Efficient Therapy against Melanoma and Post-tumor Surgery Infection. Nano Letters. https://doi.org/10.1021/acs.nanolett.4c05389
Vancouver
Gong R, Yang D, Zhang C, Abbas G, Miao B, Liang Y, et al. NIR-II Light-Driven Multifunctional Nanozymes PS@CS for Efficient Therapy against Melanoma and Post-tumor Surgery Infection. Nano Letters. 2024. doi:10.1021/acs.nanolett.4c05389
BibTeX
@article{Gong2024,
author = {Gong, Rui and Yang, Decai and Zhang, Cuijuan and Abbas, Ghulam and Miao, Beiping and Liang, Yueyue and Xu, Jianing and Fang, Xueyang and Ding, Hui},
title = {NIR-II Light-Driven Multifunctional Nanozymes PS@CS for Efficient Therapy against Melanoma and Post-tumor Surgery Infection},
journal = {Nano Letters},
year = {2024},
doi = {10.1021/acs.nanolett.4c05389}
}
EUVIMED